HLB Pharmaceutical Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 219

Employees

  • Stock Symbol
  • 047920

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $13.49
  • (As of Monday Closing)

HLB Pharmaceutical General Information

Description

HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

Contact Information

Website
www.hlbpharma.co.kr
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 27 Gyeonggang-ro, Namyangju-si, Gyeonggi-do
  • Namyangju-si, 445-743
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
KRX
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 27 Gyeonggang-ro, Namyangju-si, Gyeonggi-do
  • Namyangju-si, 445-743
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HLB Pharmaceutical Stock Performance

As of 21-Apr-2025, HLB Pharmaceutical’s stock price is $13.49. Its current market cap is $429M with 31.8M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.49 $13.80 $11.18 - $26.53 $429M 31.8M 724K $0.05

HLB Pharmaceutical Financials Summary

As of 31-Dec-2024, HLB Pharmaceutical has a trailing 12-month revenue of $100M.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 516,255 516,255 365,393 230,949
Revenue 100,468 100,468 103,983 83,183
EBITDA 4,724 4,724 (1,868) (1,310)
Net Income 1,480 1,480 (14,859) (9,114)
Total Assets 107,221 107,221 109,687 112,579
Total Debt 10,899 10,899 18,412 20,865
Public Fundamental Data provided by Morningstar, Inc. disclaimer

HLB Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HLB Pharmaceutical‘s full profile, request access.

Request a free trial

HLB Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HLB Pharmaceutical Investments (3)

HLB Pharmaceutical’s most recent deal was a Corporate Asset Purchase with Sears Pharmaceuticals (Rights to Rosu Duo). The deal was made on 24-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sears Pharmaceuticals (Rights to Rosu Duo) 24-Nov-2023 Corporate Asset Purchase Other Pharmaceuticals and Biotechnology
Verismo Therapeutics 27-Apr-2021 Seed Round Drug Discovery
SuperTrans Medical 07-Apr-2020 Corporate Pharmaceuticals
To view HLB Pharmaceutical’s complete investments history, request access »

HLB Pharmaceutical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view HLB Pharmaceutical’s complete esg history, request access »

HLB Pharmaceutical Exits (1)

HLB Pharmaceutical’s most recent exit was on 27-Apr-2021 from Verismo Therapeutics. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Verismo Therapeutics 27-Apr-2021 Completed
  • 2 buyers
To view HLB Pharmaceutical’s complete exits history, request access »

HLB Pharmaceutical FAQs

  • When was HLB Pharmaceutical founded?

    HLB Pharmaceutical was founded in 1998.

  • Where is HLB Pharmaceutical headquartered?

    HLB Pharmaceutical is headquartered in Namyangju-si, South Korea.

  • What is the size of HLB Pharmaceutical?

    HLB Pharmaceutical has 219 total employees.

  • What industry is HLB Pharmaceutical in?

    HLB Pharmaceutical’s primary industry is Drug Discovery.

  • Is HLB Pharmaceutical a private or public company?

    HLB Pharmaceutical is a Public company.

  • What is HLB Pharmaceutical’s stock symbol?

    The ticker symbol for HLB Pharmaceutical is 047920.

  • What is the current stock price of HLB Pharmaceutical?

    As of 21-Apr-2025 the stock price of HLB Pharmaceutical is $13.49.

  • What is the current market cap of HLB Pharmaceutical?

    The current market capitalization of HLB Pharmaceutical is $429M.

  • What is HLB Pharmaceutical’s current revenue?

    The trailing twelve month revenue for HLB Pharmaceutical is $100M.

  • What is HLB Pharmaceutical’s annual earnings per share (EPS)?

    HLB Pharmaceutical’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »